| mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
2e-06 |
| mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
3e-06 |
| mRNA |
TL-2-105 |
GDSC1000 |
pan-cancer |
AAC |
-0.15 |
5e-06 |
| mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
8e-06 |
| mRNA |
austocystin d |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
1e-05 |
| mRNA |
Docetaxel |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
1e-05 |
| mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
2e-05 |
| mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
4e-05 |
| mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
8e-05 |
| mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0001 |